Haemonetics Stock Performance

HAE Stock  USD 59.46  1.77  3.07%   
The company retains a Market Volatility (i.e., Beta) of -0.53, which attests to possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Haemonetics are expected to decrease at a much lower rate. During the bear market, Haemonetics is likely to outperform the market. At this point, Haemonetics has a negative expected return of -0.34%. Please make sure to check out Haemonetics' downside deviation, total risk alpha, value at risk, as well as the relationship between the information ratio and treynor ratio , to decide if Haemonetics performance from the past will be repeated at some point in the near future.

Risk-Adjusted Performance

Weakest

 
Weak
 
Strong
Over the last 90 days Haemonetics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain rather sound which may send shares a bit higher in March 2026. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders. ...more

Actual Historical Performance (%)

One Day Return
3.07
Five Day Return
(8.52)
Year To Date Return
(25.66)
Ten Year Return
86.1
All Time Return
901.43
Last Split Factor
2:1
Last Split Date
2012-12-03
1
Heres Why Haemonetics is a Strong Growth Stock
12/19/2025
2
Strong Results Lifted Haemonetics Corporation in Q4
01/23/2026
3
Stryker Surpasses Q4 Earnings and Revenue Estimates
01/29/2026
4
Haemonetics Q3 2026 Earnings Preview
02/04/2026
5
Haemonetics Q3 Earnings and Revenues Beat Estimates
02/05/2026
6
HAE Q4 Deep Dive Plasma Momentum and Hospital Weakness Shape Mixed Results
02/06/2026
7
Haemonetics International Revenue Performance Explored
02/10/2026
Begin Period Cash Flow178.8 M
Total Cashflows From Investing Activities-161.9 M

Haemonetics Relative Risk vs. Return Landscape

If you would invest  7,391  in Haemonetics on November 13, 2025 and sell it today you would lose (1,445) from holding Haemonetics or give up 19.55% of portfolio value over 90 days. Haemonetics is generating negative expected returns assuming volatility of 2.1264% on return distribution over 90 days investment horizon. In other words, 19% of stocks are less volatile than Haemonetics, and above 99% of all equities are expected to generate higher returns over the next 90 days.
  Expected Return   
       Risk  
Considering the 90-day investment horizon Haemonetics is expected to under-perform the market. In addition to that, the company is 2.73 times more volatile than its market benchmark. It trades about -0.16 of its total potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.12 per unit of volatility.

Haemonetics Target Price Odds to finish over Current Price

The tendency of Haemonetics Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move above the current price in 90 days
 59.46 90 days 59.46 
about 98.0
Based on a normal probability distribution, the odds of Haemonetics to move above the current price in 90 days from now is about 98.0 (This Haemonetics probability density function shows the probability of Haemonetics Stock to fall within a particular range of prices over 90 days) .
Considering the 90-day investment horizon Haemonetics has a beta of -0.53. This usually indicates as returns on the benchmark increase, returns on holding Haemonetics are expected to decrease at a much lower rate. During a bear market, however, Haemonetics is likely to outperform the market. Additionally Haemonetics has an alpha of 0.3627, implying that it can generate a 0.36 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta).
   Haemonetics Price Density   
       Price  

Predictive Modules for Haemonetics

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Haemonetics. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
57.7159.8461.97
Details
Intrinsic
Valuation
LowRealHigh
53.5171.7473.87
Details
10 Analysts
Consensus
LowTargetHigh
80.0888.0097.68
Details
Earnings
Estimates (0)
LowProjected EPSHigh
1.231.271.25
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Haemonetics. Your research has to be compared to or analyzed against Haemonetics' peers to derive any actionable benefits. When done correctly, Haemonetics' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Haemonetics.

Haemonetics Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Haemonetics is not an exception. The market had few large corrections towards the Haemonetics' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Haemonetics, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Haemonetics within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
0.36
β
Beta against Dow Jones-0.53
σ
Overall volatility
7.80
Ir
Information ratio 0.05

Haemonetics Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Haemonetics for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Haemonetics can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Haemonetics generated a negative expected return over the last 90 days
Haemonetics has a strong financial position based on the latest SEC filings
Over 99.0% of the company shares are owned by institutional investors
Latest headline from finance.yahoo.com: Haemonetics International Revenue Performance Explored

Haemonetics Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Haemonetics Stock often depends not only on the future outlook of the current and potential Haemonetics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Haemonetics' indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding50.7 M
Cash And Short Term Investments306.8 M

Haemonetics Fundamentals Growth

Haemonetics Stock prices reflect investors' perceptions of the future prospects and financial health of Haemonetics, and Haemonetics fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Haemonetics Stock performance.

About Haemonetics Performance

By analyzing Haemonetics' fundamental ratios, stakeholders can gain valuable insights into Haemonetics' financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Haemonetics has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Haemonetics has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Last ReportedProjected for Next Year
Days Of Inventory On Hand 193.89  120.10 
Return On Tangible Assets 0.10  0.08 
Return On Capital Employed 0.09  0.13 
Return On Assets 0.05  0.07 
Return On Equity 0.12  0.11 

Things to note about Haemonetics performance evaluation

Checking the ongoing alerts about Haemonetics for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Haemonetics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Haemonetics generated a negative expected return over the last 90 days
Haemonetics has a strong financial position based on the latest SEC filings
Over 99.0% of the company shares are owned by institutional investors
Latest headline from finance.yahoo.com: Haemonetics International Revenue Performance Explored
Evaluating Haemonetics' performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Haemonetics' stock performance include:
  • Analyzing Haemonetics' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Haemonetics' stock is overvalued or undervalued compared to its peers.
  • Examining Haemonetics' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating Haemonetics' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Haemonetics' management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of Haemonetics' stock. These opinions can provide insight into Haemonetics' potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating Haemonetics' stock performance is not an exact science, and many factors can impact Haemonetics' stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.

Complementary Tools for Haemonetics Stock analysis

When running Haemonetics' price analysis, check to measure Haemonetics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Haemonetics is operating at the current time. Most of Haemonetics' value examination focuses on studying past and present price action to predict the probability of Haemonetics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Haemonetics' price. Additionally, you may evaluate how the addition of Haemonetics to your portfolios can decrease your overall portfolio volatility.
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
AI Portfolio Prophet
Use AI to generate optimal portfolios and find profitable investment opportunities
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings